ITP
Clinical trials for ITP explained in plain language.
Never miss a new study
Get alerted when new ITP trials appear
Sign up with your email to follow new studies for ITP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to help teens with rare bleeding disorder
Disease control Recruiting nowThis study is testing a drug called efgartigimod in teenagers (12 to under 18 years old) who have chronic immune thrombocytopenia (ITP), a condition where the immune system attacks blood platelets. The main goal is to find the correct dose and see if it helps increase and maintai…
Matched conditions: ITP
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New antibody tested for rare bleeding disorder
Disease control Recruiting nowThis early-stage study is testing a new antibody drug called budoprutug in adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The main goal is to check if the drug is safe and well-tolerated, while also seeing if it helps raise plate…
Matched conditions: ITP
Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC